1324
J.-P. Cusson et al.
Paper
Synthesis
1H NMR (500 MHz, CDCl3): δ = 7.05 (d, J = 8.6 Hz, 2 H), 6.84–6.78 (m, 2
H), 3.79 (s, 3 H), 2.53 (dt, J = 12.0, 5.6 Hz, 1 H), 2.38–2.34 (m, 1 H),
2.34–2.28 (m, 2 H), 1.74–1.65 (m, 1 H), 1.62–1.53 (m, 2 H), 1.46–1.38
(m, 1 H), 1.31–1.22 (m, 6 H), 1.14 (dd, J = 18.5, 11.4 Hz, 1 H), 0.89 (d,
J = 6.9 Hz, 3 H), 0.84 (d, J = 6.9 Hz, 3 H).
(2) (a) Romero, P. E.; Piers, W. E.; McDonald, R. Angew. Chem. Int.
Ed. 2004, 43, 6161. (b) Ung, T.; Hejl, A.; Grubbs, R. H.; Schrodi, Y.
Organometallics 2004, 23, 5399. (c) Kingsbury, J. S.; Harrity, J. P.
A.; Bonitatebus, P. J. Jr.; Hoveyda, A. H. J. Am. Chem. Soc. 1999,
121, 791.
(3) (a) Shiina, I. Chem. Rev. 2007, 107, 239. (b) Deiters, A.; Martin, S.
F. Chem. Rev. 2004, 104, 2199.
13C NMR (75 MHz, CDCl3): δ = 179.2, 157.7, 134.4, 130.0, 113.7, 55.4,
46.1, 36.3, 34.0, 29.6, 29.5, 28.6, 27.4, 24.8, 19.3, 18.9.
(4) (a) Takahashi, T.; Wataqnabe, H.; Kitahara, T. Heterocycles 2002,
58, 99. (b) Baba, Y.; Saha, G.; Nakao, S.; Iwata, C.; Tanaka, T.;
Ibuka, T.; Ohishi, H.; Takemoto, Y. J. Org. Chem. 2001, 66, 81.
(c) Niwa, H.; Wakamatsu, K.; Yamada, K. Tetrahedron Lett. 1989,
30, 4543.
HRMS (ESI): m/z [M + Na]+ calcd for C18H28NaO3: 411.3258; found:
411.3277.
2-Isopropyl-8-(4-methoxybenzyl)octanoic Acid (12c)
Following the typical procedure for 11a and 12a gave 12c (19 mg,
41%) as a clear oil; Rf = 0.11 (EtOAc–hexanes, 1:9); [α]D –5 (c 1.0,
CHCl3).
(5) (a) Crimmins, M. T.; Brown, B. H. J. Am. Chem. Soc. 2004, 126,
10264. (b) Crimmins, M. T.; Emmitte, K. A.; Choy, A. L. Tetrahe-
dron 2002, 58, 1817. (c) Crimmins, M. T.; Emmitte, K. A. J. Am.
Chem. Soc. 2001, 123, 1533. (d) Crimmins, M. T.; Emmitte, K. A.
Synthesis 2000, 899.
(6) For an overview, see: Rousseau, G. Tetrahedron 1995, 51, 2777.
(7) Hanessian, S.; Guesné, S.; Chénard, E. Org. Lett. 2010, 12, 1816.
(8) (a) Maibaum, J.; Feldman, D. L. Annu. Rep. Med. Chem. 2009, 44,
105. (b) Jensen, C.; Herold, P.; Brunner, H. R. Nat. Rev. Drug Dis-
covery 2008, 7, 399. (c) Siragy, H. M.; Kar, S.; Kirkpatrick, P. Nat.
Rev. Drug Discovery 2007, 6, 779.
20
IR (neat): 2926, 2854, 1700, 1511, 1464, 1298, 1176, 1116, 1037 cm–1
.
1H NMR (300 MHz, CDCl3): δ = 7.13–7.06 (m, 2 H), 6.86–6.79 (m, 2 H),
3.79 (s, 3 H), 2.58–2.50 (m, 2 H), 2.17–2.07 (m, 1 H), 1.88 (dq, J = 13.7,
6.7 Hz, 1 H), 1.67–1.45 (m, 4 H), 1.44–1.19 (m, 7 H), 0.97 (d, J = 6.7 Hz,
6 H).
13C NMR (75 MHz, CDCl3): δ = 182.4, 157.7, 135.0, 129.4, 113.8, 55.4,
52.7, 35.1, 31.8, 30.6, 29.6, 29.4, 29.2, 27.9, 20.6, 20.2.
HRMS (ESI): m/z [M + Na]+ calcd for C18H28NaO3: 411.3258; found:
411.3113.
(9) Schwab, P.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1996,
118, 100.
(10) (a) Nam, G.; Ko, S. Y. Helv. Chim. Acta 2012, 95, 1937. (b) Slade,
J.; Liu, H.; Prashad, M.; Prasad, K. Tetrahedron Lett. 2011, 52,
4349. (c) Dong, H.; Zhang, Z.-L.; Huang, J.-H.; Ma, R.; Chen, S.-
H.; Li, G. Tetrahedron Lett. 2005, 46, 6337.
(11) For a summary, see: Yokokawa, F.; Maibaum, J. Expert Opin.
Ther. Pat. 2008, 18, 581; and references cited therein.
(12) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1,
953.
(13) Hanessian, S.; Chénard, E. Org. Lett. 2012, 14, 3222.
(14) Hanessian, S.; Chénard, E.; Guesné, S.; Cusson, J.-P. J. Org. Chem.
2014, 79, 9531.
(15) For examples of the use of Ti(Oi-Pr)4 in metathesis reactions see
ref. 4b and: Fürstner, A.; Langemann, K. J. Am. Chem. Soc. 1997,
119, 9130.
2-Isopropyl-7-(4-methoxybenzyl)-8-methylnonanoic Acid (12d)
Following the typical procedure for 11a and 12a gave 12d (11 mg,
20
40%). Rf = 0.12 (EtOAc–hexanes, 1:9) as a clear oil; [α]D +16 (c 0.3,
CDCl3).
IR (neat): 2925, 2860, 1704, 1511, 1461, 1375, 1245, 1178, 1038 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 10.59 (s, 1 H), 7.05 (d, J = 8.4 Hz, 2 H),
6.81 (d, J = 8.5 Hz, 2 H), 3.78 (s, 3 H), 2.51 (dd, J = 13.7, 6.6 Hz, 1 H),
2.36 (dd, J = 13.7, 7.8 Hz, 1 H), 2.13–2.05 (m, 1 H), 1.85 (dq, J = 13.7,
6.9 Hz, 1 H), 1.74–1.63 (m, 1 H), 1.60–1.49 (m, 1 H), 1.48–1.36 (m, 2
H), 1.29–1.14 (m, 6 H), 0.96–0.92 (m, 6 H), 0.88 (d, J = 6.8 Hz, 3 H),
0.84 (d, J = 6.9 Hz, 3 H).
13C NMR (101 MHz, CDCl3): δ = 181.5, 157.7, 134.4, 130.1, 113.7, 55.4,
52.6, 46.1, 36.3, 30.6, 29.5, 29.4, 28.6, 28.2, 27.7, 20.6, 20.2, 19.3, 18.8.
HRMS (ESI–): m/z [M – H]– calcd for C21H33O3: 333.2435; found:
333.2440.
(16) See the Supporting Information.
(17) For a concise review, see: Monfette, S.; Fogg, D. E. In Green
Metathesis Chemistry: Great Challenges in Synthesis, Catalysis
and Nanotechnology; Dragutan, I.; Finkelstein, E. S., Eds.;
Springer Science: New York, 2010.
(18) Ramírez-Fernández, J.; Collado, I. G.; Hernández-Galán, R.
Synlett 2008, 339.
Acknowledgment
(19) See for example: (a) Dai, W.-M.; Sun, L.; Feng, G.; Guan, Y.; Liu,
Y.; Wu, J. Synlett 2009, 2361. (b) Vassilikogiannakis, G.;
Margaros, I.; Tofi, M. Org. Lett. 2004, 6, 205. (c) Lee, C. W.;
Grubbs, R. H. J. Org. Chem. 2001, 66, 7155. (d) Fürstner, A.; Thiel,
O. R.; Blanda, G. Org. Lett. 2000, 2, 3731.
We are grateful for financial support from NSERC and FQRNT. We
thank Professor Marc Mauduit for the new generation catalysts.
Supporting Information
(20) Smith, A. B.; Kozmin, S. A.; Adams, C. M.; Paone, D. V. J. Am.
Chem. Soc. 2000, 122, 4984.
Supporting information for this article is available online at
(21) Fürstner, A.; Thiel, O. R.; Ackermann, L. Org. Lett. 2001, 3, 449.
(22) For selected reviews on using ring-closing metathesis in the
synthesis of macrolactone natural products, see (a) Gradillas,
A.; Pérez-Castells, J. Angew. Chem. Int. Ed. 2006, 45, 6086.
(b) Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Angew. Chem. Int. Ed.
2005, 44, 4490. (c) Prunet, J. Angew. Chem. Int. Ed. 2003, 42,
2826.
S
u
p
p
ortioInfgrmoaitn
S
u
p
p
ortiInfogrmoaitn
References
(1) (a) Handbook of Metathesis; Vols. 1–3; Grubbs, R. H., Ed.; Wiley-
VCH: Weinheim, 2003. (b) Grubbs, R. H.; Chang, S. Tetrahedron
1998, 54, 4413.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2015, 47, 1317–1324